CLINICAL_TRIALS
trial_result
· 2018-02-06
Clinical Trial Update: Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease [Phase 1, Phase 2]
Summary
Phase 1/2 trial update evaluating safety and efficacy of albuterol in individuals with Pompe disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Pompe Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-02-06